Wegovy and pregnancy: the straight answer

Step one: if you're pregnant now, stop and call your clinician

The first move is simple. If a test comes back positive while you're on Wegovy, stop taking it and get in touch with your GP, midwife or prescriber as soon as you reasonably can. There's no need to panic, but there is a need to act. Wegovy carries no UK licence for use in pregnancy, and the safety information reflects that semaglutide is not recommended for pregnant women.

People often assume that one missed injection or a dose taken before they knew they'd conceived has done harm. That worry is understandable, and it's worth putting gently to one side: the sensible response is to stop and speak to someone qualified, not to spend the evening reading worst-case threads online. Your clinician can talk through the specifics of your dose, your timing and your general health.

Because semaglutide is a once-weekly injection, it clears from the body slowly rather than overnight. That's one reason the medicine is stopped well ahead of a planned pregnancy where possible. The NHS medicines information on semaglutide and its use in pregnancy is a reliable starting point, and our own page on what to do if you're pregnant while taking Wegovy walks through the same ground in more detail. The headline stays the same across all of them: stop, then talk to a professional who can look at your full picture.

Step two: understand what the evidence does and doesn't tell us

Here's the honest position. The reason Wegovy isn't recommended in pregnancy is not a long list of proven harms in humans. It's an absence of good human safety data, combined with animal studies that raised concerns about effects on developing offspring. When a medicine hasn't been studied properly in pregnant people, regulators take the cautious route, and semaglutide sits firmly in that cautious category.

Semaglutide is a GLP-1 receptor agonist that works partly by slowing how quickly your stomach empties and by reducing appetite. Neither of those effects is something you want steering a pregnancy, where steady nutrition matters enormously. Rapid weight loss during pregnancy isn't a goal for anyone; the priority becomes supporting a healthy weight gain appropriate to the stage.

What remains uncertain is the precise level of risk from an accidental exposure early on, before anyone knew. Real-world data is still being gathered, which is exactly why a pregnancy registry exists for people exposed to semaglutide. If you'd like the underlying mechanism explained plainly, our page on how semaglutide may affect pregnancy covers it. The takeaway is measured, not alarmist: we don't have enough evidence to call it safe, so it isn't used.

Step three: plan the wash-out window before trying to conceive

If a baby is part of your plans, timing matters. UK guidance advises stopping semaglutide and allowing a wash-out period before you actively try to conceive, rather than stopping the day you decide to start trying. Because Wegovy is a once-weekly medicine that lingers in the system, that window is not a matter of a few days.

The exact length of time to leave between your last dose and trying for a baby is a clinical judgement, and it's one to make with your prescriber rather than guess at. The MHRA advises contraception while on GLP-1 medicines precisely so that this planning can happen deliberately. That's the practical reason our prescribers raise family planning during a consultation, not to pry, but because the timing genuinely affects your treatment.

There's a common misconception worth naming here: some people assume Wegovy acts as a contraceptive because appetite and weight change so noticeably. It doesn't. If preventing pregnancy matters to you while you're on treatment, you still need proper contraception, and our page on whether Wegovy affects contraception explains why. For the forward-planning side, stopping Wegovy before pregnancy sets out the sequence, and trying to conceive after Wegovy covers what comes next.

Step four: know why weight loss pauses once you're expecting

Deliberate weight loss is not the objective during pregnancy, even for people who started treatment with a high BMI. Your body is doing an enormous amount of work, and appropriate weight gain is part of a healthy pregnancy. This is why Wegovy, whose whole purpose is to reduce appetite and support weight loss, has no place in the schedule once you've conceived.

That can feel disorienting if you've spent months building momentum and are watching progress you worked hard for. It's a reasonable thing to feel. The reframe our prescribers offer is that this is a pause with a clear medical reason, not a failure, and that treatment options can be revisited afterwards under proper supervision.

Your maternity team, including your midwife and GP, becomes the right source of advice on nutrition, activity and healthy weight gain during this period. For general grounding, the NHS healthy weight guidance is sensible reading, though nothing replaces a plan built for your pregnancy by the people caring for you. If diabetes is part of your history, the interaction between pregnancy and blood-sugar management is its own conversation, and our page on Wegovy and type 2 diabetes gives useful background before you speak to your team.

Step five: handle breastfeeding as its own separate question

Breastfeeding is not simply an extension of the pregnancy rule; it's a distinct question with its own cautious answer. Wegovy is not recommended while you're breastfeeding, again because there isn't enough evidence about semaglutide passing into breast milk or affecting a nursing infant. As with pregnancy, the absence of reassuring data leads to a conservative stance.

Many people expect to restart weight-management treatment the moment their baby arrives. In practice, if you're breastfeeding, that restart is usually delayed, and the timing depends on your feeding plans and your health. This is genuinely individual, so it's a conversation to have with your prescriber or GP rather than a decision to make from a forum post.

If you're weighing up feeding choices alongside your own health goals, it helps to separate the two decisions and take them in order: feed your baby the way that works for you and them, then plan any return to treatment around that. Our page on Wegovy while breastfeeding goes into the specifics, and the broader picture of semaglutide across pregnancy and beyond ties the phases together. The principle stays consistent throughout: where we lack evidence of safety, the medicine is held back.

Step six: talk to the right person, at the right time

Who you speak to depends on where you are. If you're already pregnant, your midwife and GP lead, with your maternity team overseeing your care. If you're planning a pregnancy, your prescriber and GP are the people to involve early, so the wash-out timing and any changes to related medicines are handled properly rather than improvised.

At nume, family planning is part of the clinical conversation, not an afterthought. Our prescribers are GPhC-registered Independent Prescribers, and a real clinician reads your answers rather than an algorithm sorting you into a box. That matters most in situations exactly like this one, where the right answer depends on your history, your timing and your goals rather than a generic rule.

You can verify any UK online pharmacy on the GPhC register of pharmacies before you trust it with a prescription-only medicine, which is a habit worth keeping. If you're unsure whether to pause, stop or wait, the safest move is always to ask a qualified person. Speak to our prescribers before making any change to your treatment around a pregnancy. And if fertility itself is on your mind, our page on semaglutide and fertility is a useful next read.

Step seven: keep the wider safety picture in view

Pregnancy planning doesn't happen in isolation from the rest of your health, and a few threads are worth holding together. If you have conditions such as PCOS, weight and fertility can be closely linked, and treatment decisions get more nuanced; our page on Wegovy and PCOS is a helpful place to explore that overlap before a consultation.

It's also worth remembering that semaglutide's cautious pregnancy stance is one part of a broader safety profile. Common side effects are largely gastrointestinal and tend to settle after starting, but any GLP-1 medicine deserves a proper conversation about your whole history. Reporting anything unexpected through the MHRA Yellow Card scheme helps build the real-world evidence that guidance like this depends on.

The message across every one of these steps is consistent and calm. Wegovy in pregnancy is not recommended, pregnancy on Wegovy means stopping and seeking advice, and pregnancy after Wegovy is planned deliberately with a clinician. None of it needs to be frightening; it needs to be handled by the right people at the right time.

Related questions we've answered

• Can Wegovy affect a pregnancy?
• Taking Wegovy while pregnant
• What if I got pregnant on Wegovy?
• Semaglutide during pregnancy
• Semaglutide's pregnancy category explained